Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (11-20 of 394) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|October 13, 2023
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?Jordan J Feld
Clinical Liver Disease|July 2, 2024
Novel biomarkers for HBV including point-of-careJordan J Feld
Journal of Hepatology|April 24, 2012
Interferon responses and spontaneous HCV clearance: is it all a matter of fat?Jordan J Feld
Current Drug Targets|August 26, 2015
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress ContinuesJordan J Feld
Clinical Liver Disease|June 13, 2019
HCV infection on-treatment viral kinetics: Do they still have a role?Jordan J Feld
Nature Reviews. Gastroenterology & Hepatology|May 6, 2016
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insightsMatthias Götte, Jordan J Feld
Gut|February 20, 2016
One small SNP for receptor virus entry, one giant leap for hepatitis B?Neil Rajoriya, Jordan J Feld
Clinical Liver Disease|May 2, 2019
Defining and grading HBV reactivationAlissa Visram, Jordan J Feld
Gastroenterology|December 24, 2013
Does eltrombopag really ENABLE SVR?Aviva Leber, Jordan J Feld
The New England Journal of Medicine|May 3, 2016
Sofosbuvir and Velpatasvir for Patients with HCV InfectionJordan J Feld, Stefan Zeuzem
Pageof 40

Showing results (11-20 of 394) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|October 13, 2023
What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?Jordan J Feld
Clinical Liver Disease|July 2, 2024
Novel biomarkers for HBV including point-of-careJordan J Feld
Journal of Hepatology|April 24, 2012
Interferon responses and spontaneous HCV clearance: is it all a matter of fat?Jordan J Feld
Current Drug Targets|August 26, 2015
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress ContinuesJordan J Feld
Clinical Liver Disease|June 13, 2019
HCV infection on-treatment viral kinetics: Do they still have a role?Jordan J Feld
Nature Reviews. Gastroenterology & Hepatology|May 6, 2016
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insightsMatthias Götte, Jordan J Feld
Gut|February 20, 2016
One small SNP for receptor virus entry, one giant leap for hepatitis B?Neil Rajoriya, Jordan J Feld
Clinical Liver Disease|May 2, 2019
Defining and grading HBV reactivationAlissa Visram, Jordan J Feld
Gastroenterology|December 24, 2013
Does eltrombopag really ENABLE SVR?Aviva Leber, Jordan J Feld
The New England Journal of Medicine|May 3, 2016
Sofosbuvir and Velpatasvir for Patients with HCV InfectionJordan J Feld, Stefan Zeuzem
Pageof 40